Safety of perioperative aprotinin administration during isolated coronary artery bypass graft surgery: Insights from the ART (Arterial Revascularization Trial)
Background: There is still uncertainty about the safety of aprotinin for coronary artery bypass graft (CABG) surgery. The Arterial Revascularization Trial (ART) was designed to compare survival after bilateral vs single internal thoracic artery grafting. A large proportion of the ART patients (~30%) received perioperative aprotinin. We investigated the association between perioperative Aprotinin administration and short (in-hospital) and long-term outcomes by performing a pos... Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's version
- American Heart Association Publisher's website
- Journal of the American Heart Association Journal website
- Article: e007570
- Publication date:
- Acceptance date:
- Pubs id:
- Local pid:
- Copyright holder:
- Benedetto et al.
- Copyright date:
© 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.